Open AccessSevere pancytopenia caused by trifluridine/tipiracil in patients with metastatic colorectal cancer and an impaired renal function: A case report
Author(s) -
Shibutani Masatsune,
Okazaki Yuki,
Kashiwagi Shinichiro,
Nagahara Hisashi,
Fukuoka Tatsunari,
Iseki Yasuhito,
Maeda Kiyoshi,
Hirakawa Kosei,
Ohira Masaichi
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5544
Subject(s) - medicine , pancytopenia , colorectal cancer , impaired renal function , oncology , renal function , cancer , bone marrow
Although the incidence of hematological toxicity due to Trifluridine/tipiracil (FTD/TPI) treatment is high, the incidence of severe adverse events has been reported to be relatively low. However, it should be noted that patients with renal impairment are prone to severe hematological adverse events.